BIOLOGICAL RESEARCH

Uzbekov M.G., Maximova N.M., Brilliantova V.V., Shikhov S.N., Moskvitina T.A., Uzbekova D.G., Gorobets L.N., Strelkova I.M., Bulatetsky S.V., Smolina N.V. (Moscow, Ryazan) On the issue of biological markers of efficiency of therapy of mental and neurologic diseases ……………………………………………………………………………………………………

Markova Е.V., Anikeeva O.S, Savkin I.V., Kozlov V.A. (Novosibirsk) Neuroimmune parameters in adult recipients after the repeated transplantation of immune cells with different functional characteristics which was held in the juvenile development period …………………………………………………………………………………………………………………………………

Ivanova S.A., Osmanova D.Z., Boiko A.S., Pozhidaev I.V., Fedorenko O.Yu., Vyalova N.M., Poltavskaya E.G., Tiguntsev V.V., Freidin M.B., Kornetova E.G., Semke A.V.  (Tomsk) Antipsychotic-induced hyperprolactinemia: pharmacogenetic aspects ………………………………………………………………………………………………………………………………….

Solonsky A.V., Prokopieva V.D, Yarygina E.G. (Tomsk) Neuromorphological and molecular effects of ethanol ………………

Smirnova L.P., Parshukova D.A., Ermakov E.A., Dmitrieva E.M., Boiko A.S., Fedorenko O.Yu, Loginova L.V., Krotenko N.M., Seregin A.A., Letova A.A., Sinyansky L.E., Kornetova E.G., Ivanova S.A. (Tomsk, Novosibirsk)  Outcomes of search for biomarkers of schizophrenia ……………………………………………………………………………………………………..

Nikitina V.B., Lobacheva O.A, Vetlugina T.P., Axenov M.M, Lebedeva V.F. (Tomsk) Neuroimmunoendocrine dysfunctions in mental disorders and addictions …………………………………………………………………………………………………..

Nevidimova T.I., Savochkina D.N., Masterova E.I., Bokhan N.A. (Tomsk) Results and prospects of research of interaction between sensory and immune systems in addictive disorders ……………………………………………………………………….

Klyushnik T.P., Androsova L.V., Zozulya S.A., Otman I.N., Nikitina V.B., Vetlugina T.P.  (Moscow, Tomsk) Comparative analysis of inflammatory markers in endogenous and non-psychotic mental disorders ……………………………………………..

5

15

21

28

33

45

56

64

PENITENTIARY PSYCHIATRY

Yakhimovich L.A., Makushkina O.A.(Moscow) Clinical aspects of social danger of schizophrenia patients …………………..

70

CHILD-ADOLESCENT PSYCHIATRY

Sakharov A.V., Klinova M.A., Bondarenko A.V., Stupina O.P. (Chita) Socio-psychological and clinical characteristics of adolescents in Trans-Baikal Krai who have committed crime acts (based on forensic psychiatric expertise) ………………………

77

CLINICALADDICTIONPSYCHIATRY

Nikolishin A.E., Brodyansky V.М., Chuprova N.A., Sulimov G.Yu, Kibitov А.О. (Moscow) In search for hereditary form of alcohol addiction: Cloninger’s typology, dynamics of withdrawal formation, family history and evaluation of genetic risk……….

Maksimova I.V. (Krasnoyarsk) Cognitive and electroencephalographic changes in patients undergoing a seizure, suffering from alcohol dependence …………………………………………………………………………………………………………………..

Bokhan N.A., Selivanov G.Yu., Blonsky K.A., Lavrova U.A. (Tomsk, Seversk, Nizhnevartovsk) Features of socio-psychological adaptation of patients with paranoid form of schizophrenia complicated by synthetic cannabinoids (spice) dependence …………………………………………………………………………………………………………………………………..

82

89

93

lectures. reviews

Idova G.V., Alperina E.L., Zhanaeva S.Ya., Gevorgyan M.M.(Novosibirsk) Neuroimmune mechanisms of neurodegenerative disorders: role of cytokines and toll-like receptors ……………………………………………………………………………..

Yanushko M.G., Sosin D.N., Shamanina M.V., Ivanov M.V (Saint-Petersburg)Cognitive-specific genetic correlates in schizophrenia (review) …………………………………………………………………………………………………………………….

Skutin A.V., Efimenko T.S., Shaikhetdinov R.G., Gromov V.A. (Chelyabinsk) Pathways and neuroanatomical correlates of symptomatic (pathological), normal (emotional) and voluntarily caused laughter  (review of foreign literature)…………………..

99

105

111

Psychopharmacotherapy

Shushpanova T.V., Novozheeva T.P., Mandel A.I., Knyazeva E.M. (Tomsk) Molecular targets of action of innovative anticonvulsant galodif in therapy of alcohol dependence ………………………………………………………………………………..

Gorobets L.N., Bulanov V.S., Litvinov A.V. (Moscow) Indices of cortisol and dehydroepiandrosterone sulfate as potential biomarkers of efficiency of antipsychotic therapy in first psychotic episode patients ………………………………………………

120

127